# Maxcyte, Inc.: Form 8-K, filed Aug 4, 2021

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: 8-K
- Filed: 2021-08-04
- Accepted by EDGAR: Aug 4, 2021, 16:06 ET
- Period: 2021-08-03
- Accession: 0001104659-21-100067
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000110465921100067/tm2113965d16_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000110465921100067/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000110465921100067/tm2113965d16_8k.htm

Filed Aug 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-100067. Last ingested by Listed: Nov 11, 2026, 01:53 ET. No prices; not investment advice.
